| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 144.095 | 176.724 | 294.526 | 399.941 | 439.597 | 423.436 |
| Total Income - EUR | - | - | - | 0 | 145.490 | 177.221 | 294.537 | 399.947 | 451.381 | 449.755 |
| Total Expenses - EUR | - | - | - | 0 | 77.048 | 116.312 | 168.198 | 207.124 | 245.164 | 248.828 |
| Gross Profit/Loss - EUR | - | - | - | 0 | 68.442 | 60.908 | 126.338 | 192.823 | 206.217 | 200.928 |
| Net Profit/Loss - EUR | - | - | - | 0 | 66.987 | 59.477 | 123.727 | 188.817 | 202.243 | 188.245 |
| Employees | - | - | - | 0 | 3 | 3 | 2 | 4 | 5 | 3 |
Check the financial reports for the company - Dermisana Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 26 | 53.989 | 73.521 | 127.738 | 167.327 | 338.974 | 273.551 |
| Current Assets | - | - | - | 43 | 42.226 | 45.867 | 96.831 | 120.679 | 99.475 | 256.250 |
| Inventories | - | - | - | 0 | 11.937 | 13.581 | 68.561 | 26.037 | 30.049 | 34.817 |
| Receivables | - | - | - | 0 | 28.217 | 1.039 | 0 | 587 | 15.571 | 0 |
| Cash | - | - | - | 43 | 2.072 | 31.246 | 28.271 | 94.055 | 53.855 | 221.433 |
| Shareholders Funds | - | - | - | 43 | 67.030 | 98.360 | 206.074 | 191.667 | 272.445 | 190.862 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 26 | 29.186 | 21.027 | 18.495 | 96.339 | 10.339 | 178.300 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 155.666 | 160.638 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermisana Medical S.r.l.